FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Propofol Injectable Emulsion
Status: Currently in Shortage
»Date first posted: 04/10/2020
»Therapeutic Categories: Anesthesia

Expand all

Dr. Reddy's Laboratories, Inc. (Reverified 09/21/2020)

Company Contact Information:
866-732-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200mg/20mL 10ct (NDC 43598-265-58) Limited supply, resupply TBD Manufacturer extended lead times

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug
200mg/20mL vial, individual (NDC 43598-265-20) Limited supply, resupply TBD Manufacturer extended lead times

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug
500mg/50mL 20ct (NDC 43598-548-21) Limited supply, resupply TBD Manufacturer extended lead times Demand increase for the drug
500mg/50mL vial, individual (NDC 43598-548-50) Limited supply, resupply TBD Manufacturer extended lead times

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug
1000mg/100mL vial, 10ct (NDC 43598-549-10) Limited supply, resupply TBD Manufacturer extended lead times Demand increase for the drug
1000mg/100mL vial, individual (NDC 43598-549-52) Limited supply, resupply TBD Manufacturer extended lead times.

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug
200mg/20mL vial, 25ct (NDC 43598-265-25) Limited supply, resupply TBD Manufacturer extended lead times. Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 09/15/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10) Shipping / Check wholesaler inventory
200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29) Shipping / Check wholesaler inventory Demand increase for the drug
500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50) Allocating to wholesalers / Check wholesaler inventory COVID-19 demand Demand increase for the drug
1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65) Allocating to wholesalers / Check wholesaler inventory COVID-19 demand Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (New 07/23/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL vial (NDC 0641-6194-10) This presentation is currently available. Additional lots are scheduled for manufacturing. Product will be made available as it is released. Demand increase for the drug
10 mg/mL, 50 mL vial (NDC 0641-6195-20 This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing in the August – September 2020 timeframe. Product will be made available as it is released. Demand increase for the drug
10 mg/mL, 100 mL vial (NDC 0641-6196-10 This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing in the August – September 2020 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Revised 09/24/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg/20 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-30) Limited Supply Available. Next Delivery and Estimated Recovery: October 2020 Demand increase for the drug
500 mg/50 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-33) Limited Supply Available. Next Delivery: September 2020; Estimated Recovery: November 2020 Demand increase for the drug
1000 mg/100 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-24) Limited Supply Available. Next Delivery and Estimated Recovery: September 2020 Demand increase for the drug

Sagent Pharmaceuticals (Reverified 09/22/2020)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200mg per 20ml (NDC 25021-608-20) Available. On Allocation Demand increase due to Covid-19
500mg per 50ml (NDC 250-21-608-50) Available. On Allocation Demand increase due to Covid-19
1000mg per 100ml (NDC 25021-608-51) Available. On Allocation Demand increase due to Covid-19

Teva Pharmaceuticals (Reverified 09/17/2020)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10MG/ML 10X100ML VL (NDC 0591-2136-68) Limited supply available. Next Delivery and Estimated Recovery: TBD Supply chain has been impacted by shipping delays due to COVID-19 Other
10MG/ML 20X50ML VL (NDC 0591-2136-51) Limited supply available. Next Delivery and Estimated Recovery: TBD Supply chain has been impacted by shipping delays due to COVID-19 Other
10MG/ML 25X20ML VL (NDC 0591-2136-95) Limited supply available. Next Delivery and Estimated Recovery: TBD Supply chain has been impacted by shipping delays due to COVID-19 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English